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Beyond Single Channel Variants*
Dawood Darbar, MD, Babar Parvez, MD,
Robert Abraham, MD
Nashville, Tennessee
Atrial fibrillation (AF), the most common sustained
cardiac arrhythmia, represents a major health burden to
people and health care systems within the Western world
(1). Given its increasing prevalence with age, coupled
with the aging population, the number of Americans
affected is expected to surge from approximately 2.3
million in the year 2000 to nearly 16 million by 2050 (2).
Until recently, AF was considered to be a sporadic, nonge-
netic disorder. However, we and others have shown that
lone AF has a substantial genetic basis. Mutations in genes
encoding cardiac ion channels, gap junction proteins, and
signaling molecules have been reported in isolated cases and
small families (3–5).
See page 1017
The advent of the human genome project, HapMap
project, and high-throughput genotyping has accelerated
our ability to discover the genetic contribution to common
variation in human disease. In 2007, a genome-wide asso-
ciation (GWA) study identified 2 common AF susceptibil-
ity variants on chromosome 4q25 (6). More recently, 2
additional AF loci on chromosomes 16q22 (7,8) and 1q21
(9) have been identified. It is quite likely, however, that the
effects of alleles in many genes and interactions among those
gene products contribute to complex diseases such as AF
(5). Although GWA studies have identified hundreds of
variants associated with common human diseases, and have
provided valuable insights into the genetic architecture of
complex traits, individually these loci confer relatively small
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to disclose.increments in AF risk (odds ratios 1.1 to 2.0) and explain
10% of the heritability of lone AF. This raises the
possibility that a combination of variants with intermediate
effects may account for a large fraction of the risk for lone
AF (10,11).
The development of methods for coupling targeted cap-
ture and massively parallel deoxyribonucleic acid sequencing
now allows cost-effective determination of all of the coding
variation present in an individual genome. Whole exome
sequencing is a powerful new approach to identify genes
that underlie not only Mendelian disorders but also diseases
that do not exhibit simple Mendelian transmission (complex
traits). This approach has been utilized successfully to
identify variability in protein-coding regions that alter risk
for hyperlipidemia (12) and autism (13). In addition, exome
sequencing of candidate ion channels genes in patients with
idiopathic epilepsy has also demonstrated that rare disease-
associated variants in known Mendelian disease genes were
also present in a majority of healthy control subjects (14).
These data would go against the prevalent dogma that rare
variants are always disease causing or disease associated.
Furthermore, the importance of evaluating total variant
burden in an individual patient is emphasized when esti-
mating the susceptibility to development of a disease.
In contrast to the single candidate gene approach, com-
binations of common and rare gene variants may play a
central role in disease susceptibility (15). Epistasis, namely,
gene-gene interaction, is recognized as prevalent in the
genetic architecture of many complex traits. Given the
inherent difficulty of evaluating multiple combinations of
gene variants in vivo or in vitro, the development of in silico
methods for modeling these combined effects will be critical
when trying to understand and derive meaningful informa-
tion from genomic data.
Potassium channels play a central role in atrial repolar-
ization, and mutations in genes that encode for the cardiac
potassium channels have been associated with AF. In this
issue of the Journal, Mann et al. (16) evaluated the role of
these gene variants in families with AF. They tested the
hypothesis that the presence of multiple cardiac potassium
ion channel variants may exhibit epistatic effects that con-
tribute to an arrhythmogenic atrial substrate and lead to
increased AF susceptibility. Genes encoding the major
cardiac potassium channels were resequenced in 80 AF
probands. Nonsynonymous variants identified in AF pro-
bands were then evaluated in 240 healthy controls. Novel
variants were functionally characterized using conventional
patch-clamp techniques. Nineteen nonsynonymous variants
in 9 potassium channel genes were identified, including 11
rare variants (minor allele frequency 1%). These variants
were also present in healthy controls; however, 6 of the 11
rare variants were only present in persons with AF. Overall,
rare variants were present in a higher proportion of AF
probands than controls, but there was no difference in the
number and distribution of common and uncommon vari-
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though 75% of the probands had 2 or more variants, only
novel variants in KCNA5 (G568V [gain-of-function IKur])
nd KCNH2 (E444K [loss-of-function IKr]) segregated,
albeit modestly, with AF within the families. Whole-cell
voltage clamp analysis showed that most novel variants had
demonstrable electrophysiologic effects, with 9 of the 19
variants also having validated or predicted effects on protein
phosphorylation or protein-protein interactions.
To evaluate the effect of combinations of variants on
magnitude and dispersion of action potential duration
(APD), Mann et al. (16) performed in silico modeling using
the Courtemanche atrial cell model simulations. The sen-
sitivity of APD to changes in the magnitude of 5 potassium
currents (Ito, IKur, IKr, IKs, IK1) was established, with IK1 and
IKr having the highest sensitivity coefficients. Small random
ariations in IKr magnitude (20%) had significant effects
n mean APD90 but minimal effect on APD dispersion.
onversely, changing IKur magnitude (20%) produced
significant alteration in APD dispersion but minimal
change in mean APD90. The effects of 2 potassium channel
ariants, as observed in 1 family (KCNA5-G568V and
CNH2-R1047L), was simulated by increasing IKur mag-
nitude by 20% and decreasing IKr magnitude by 20%. These
changes in current densities had an additive non-linear
ffect on APD90 (see Fig. 2 of Mann et al. [16]).
In light of their observation of multiple potassium chan-
nel variants being present in different AF pedigrees, Mann
et al. (16) also examined the functional consequences of 243
combinations with 10% change in baseline current levels
of all 5 potassium channels. The combination of 10%
reduction in IK1, IKr, IKs with simultaneous 10% increase in
Kur and Ito gave the longest APD90. This nonintuitive
esult demonstrates not only the plausibility of multiple
mall variants combining to produce an arrhythmogenic
ubstrate, but also the indispensability of computer simula-
ion to discover and evaluate combinations of variants.
Notwithstanding these important contributions, 2 limi-
ations need to be addressed. First, as the authors point out,
nly potassium channel variants were evaluated in this
tudy. Variants in the genes that encode for other constit-
ents of the AP (e.g., sodium channel current [INa] and
-type calcium channel current [ICaL]), have previously
een shown to make important contributions to AF suscep-
ibility (17). Second, the specific ion channel variants
dentified as possibly contributory to AF were not modeled
n detail; only overall variations in current magnitude were
onsidered. Changes in channel-gating parameters (e.g.,
oltage-dependence and time constants of activation and
nactivation) may also play an important role in interactions
mong ion channels. Finally, simulation studies such as
hese, where human validation is impractical or impossible,
re inherently limited by the uncertain degree to which the
imulations reflect real human biology. However, that lim-
tation is true of any model system, including the ubiquitous
ouse model, and should not be disqualifying.Mann et al. (16) have presented convincing data support-
ng the hypothesis that the presence of rare functional
otassium channel variants of varying effect size may con-
ribute to an atrial arrhythmogenic substrate and increase
usceptibility to AF. For most of the novel rare variants
dentified, especially KCNA5-G568V and KCNH2-E444K,
n vitro analysis revealed a relatively modest effect, suggest-
ng that these rare variants by themselves may not increase
he susceptibility to AF, but require the presence of addi-
ional variants (rare or common) in combination. Using in
ilico modeling, the investigators were able to assess the
unctional consequences of multiple variants and identify
ow they may combine to substantially modulate atrial
epolarization. That is an important step towards a better
nderstanding of the role of multiple genetic variants in AF;
owever, these results must be interpreted with caution
onsidering the variability of in vivo and in vitro results (18).
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